Literature DB >> 7801936

Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.

R J Adamek, W Opferkuch, M Wegener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7801936

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.

Authors:  M Tavakoli; A T Prach; M Malek; D Hopwood; B W Senior; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981

2.  How should we decide on the best regimen for eradicating Helicobacter pylori?

Authors:  V Savarino; S Vigneri
Journal:  BMJ       Date:  1995-09-02

Review 3.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

4.  Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance.

Authors:  M Dehesa; J Larisch; M Dibildox; M Di Silvio; L H Lopez; E Ramirez-Barba; J Torres
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

Review 5.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.